{'fraction_non_alphanumeric': 0.024447031431897557, 'fraction_numerical': 0.0, 'mean_word_length': 4.972222222222222, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Why a patient may not be transfused with cell saver not-processed wound blood].

The paper gives information on different clinically important aspects associated with reinfusion of wound and drainage bloods to patients. It considers matters, such as the composition of wound and drainage bloods and its comparison with that of donor blood, as well as that of the cell-saver-washed wound blood; clinical and economic efficiency of the reinfusion of wound and drainage bloods; complications due to the reinfusion of unwashed wound and drainage bloods, as well as a number of other important aspects of the problem. Strong evidence is provided that there are presently no clinical, legal, or economic grounds for the reinfiusion of cell-saver-unwashed wound and drainage bloods in clinical practice. Only cell-saver-washed blood must be reinfiused to a patient.